EpiVario, Inc.
PrivateLast Round
Grant
Oct 1, 2024
Total Funding Raised
$1.28M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
EpiVario, Inc. is a biotechnology company that develops novel epigenetic therapeutics for the treatment of neuropsychiatric disorders, including substance use disorders and PTSD.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpiVario, Inc. Comparables
Compare EpiVario, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Embera NeuroTherapeutics | 76% | |
| Reunion Neuroscience Inc. | 72% | |
| CAD Therapeutics, Inc. | 70% |
EpiVario, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 1, 2024 | ||||
| Grant | Jun 1, 2024 | ||||
| Series A | Jan 19, 2023 | ||||
| Grant | Sep 13, 2022 | ||||
| Seed | Dec 11, 2018 |
EpiVario, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| National Institute on Alcohol Abuse and Alcoholism | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 86% MoM.
- Jul 28, 2026
Monthly visitors increased 43% MoM.
EpiVario, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EpiVario, Inc.'s valuation, stock price, and market status.
Is EpiVario, Inc. a public or private company?
EpiVario, Inc. is a private company.
What is the current stock price of EpiVario, Inc.?
EpiVario, Inc. is a private company with no public stock price. Caplight tracks EpiVario, Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is EpiVario, Inc. worth (valuation)?
Valuation information for EpiVario, Inc. is not publicly available.
Can I buy EpiVario, Inc. stock?
EpiVario, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was EpiVario, Inc.'s last funding round?
EpiVario, Inc.'s most recent funding round was Grant on October 1, 2024.
Who are the main investors in EpiVario, Inc.?
Key investors in EpiVario, Inc. include National Institute on Drug Abuse, National Institute on Alcohol Abuse and Alcoholism.
Will EpiVario, Inc. IPO soon?
No public IPO plans have been announced for EpiVario, Inc..
How can I track EpiVario, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EpiVario, Inc.'s secondary market activity and sign up for updates.